IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $507,000 | -15.9% | 15,118 | 0.0% | 0.06% | -11.3% |
| Q2 2021 | $603,000 | -11.3% | 15,118 | 0.0% | 0.07% | -19.3% |
| Q1 2021 | $680,000 | -54.0% | 15,118 | -42.1% | 0.09% | -58.1% |
| Q4 2020 | $1,477,000 | +19.1% | 26,118 | -0.1% | 0.21% | +16.7% |
| Q3 2020 | $1,240,000 | -22.1% | 26,136 | -3.2% | 0.18% | -30.2% |
| Q2 2020 | $1,592,000 | -22.7% | 27,006 | -38.0% | 0.26% | +33.7% |
| Q1 2020 | $2,060,000 | +197.7% | 43,575 | +280.3% | 0.19% | +83.8% |
| Q4 2019 | $692,000 | – | 11,458 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |